SP
Satya Prakash Shrivastava
About Satya Prakash Shrivastava
Data last updated:
Satya Prakash Shrivastava is a Director at Aimil Pharmaceuticals(India) Limited (since 2014). The company operates in Healthcare. Aimil Pharmaceuticals(India) Limited reported revenue of ₹481 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Aug 2014 | 1984 | ₹481 Cr (FY 2023) | Active |
Board colleagues of Satya Prakash Shrivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ikshit Sharma | 08618218 | Aimil Pharmaceuticals(India) Limited | Director |
| Kanwal Kumar Sharma | 00526387 | Aimil Pharmaceuticals(India) Limited | Managing Director |
| Manjula Sharma | 00526401 | Aimil Pharmaceuticals(India) Limited | Director |
| Pankaj Marwaha | 00526342 | Aimil Pharmaceuticals(India) Limited | Director |
| Sanchit Sharma | 08700130 | Aimil Pharmaceuticals(India) Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Prakash Shrivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Prakash Shrivastava
Satya Prakash Shrivastava currently holds 1 directorship: Aimil Pharmaceuticals(India) Limited (Director, since 18 Aug 2014, revenue ₹481 Cr (FY 2023)).
Satya Prakash Shrivastava was first appointed on 18 Aug 2014 as Director at Aimil Pharmaceuticals(India) Limited.
The current boards of Satya Prakash Shrivastava's companies include Ikshit Sharma (Aimil Pharmaceuticals(India) Limited), Kanwal Kumar Sharma (Aimil Pharmaceuticals(India) Limited), Manjula Sharma (Aimil Pharmaceuticals(India) Limited), Pankaj Marwaha (Aimil Pharmaceuticals(India) Limited), Sanchit Sharma (Aimil Pharmaceuticals(India) Limited).